T2 Biosystems Joins Forces with NIH in Groundbreaking Study to Revolutionize Pneumonia Diagnosis
T2 Biosystems Joins NIH-funded Pilot Study to Revolutionize Pneumonia Detection through Innovative Diagnostic ApproachesLEXINGTON, Mass., Jan. 18, 2024 - T2 Biosystems, Inc. (NASDAQ: TTOO), a prominent leader in rapid d...
Jan 18, 2024
• Medical Equipment & Supplies Industry
Clinical Study
